Compounds > sulfamethoxypyridazine
Page last updated: 2024-11-04

sulfamethoxypyridazine and Cerebral Nocardiosis

sulfamethoxypyridazine has been researched along with Cerebral Nocardiosis in 2 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
VIPULYASEKHA, S1
VATHANABHUTI, S1
da Lacaz, CS1
Minami, PS1
Fernandez, W1

Other Studies

2 other studies available for sulfamethoxypyridazine and Cerebral Nocardiosis

ArticleYear
Treatment of nocardial mycetoma with sulphamethoxypyridazine.
    The British journal of dermatology, 1960, Volume: 72

    Topics: Humans; Mycetoma; Nocardia; Nocardia Infections; Sulfamethoxypyridazine

1960
["In vitro" action of sulfamethoxypyridazine on pathogenic fungi].
    Hospital (Rio de Janeiro, Brazil), 1968, Volume: 73, Issue:6

    Topics: Animals; Antifungal Agents; Blastomycosis; Fungi; Humans; In Vitro Techniques; Nocardia Infections;

1968